ENSG00000071677 (PRLH)

homo sapiens

prolactin releasing hormone

Filter your results

Homo sapiens
Organism part
Showing 14 experiments:
Created with Highcharts 6.2.0adipose tissuebrain fragmentectocervixheartlower leg skinovarysaliva-secreting glandsuprapubic skinvaginaanterior cingulate cortexbasal ganglioncerebral cortexcoronary arteryesophagusforebrain and midbrainhypothalamusleft kidneymedulla oblongatamuscle of armponsrenal medullaskeletal muscle tissuespleenthymustibial nerve
T
HDBR developing brain - Carnegie Stage …
T
HDBR developing brain - Carnegie Stage …
T
HDBR developing brain - 10 post …
T
HDBR developing brain - Late 8 post …
T
HDBR developing brain - Carnegie Stage …
T
HDBR developing brain - Carnegie Stage …
T
HDBR developing brain - Carnegie Stage …
T
HDBR developing brain - Carnegie Stage …
T
HDBR developing brain - 9 post …
T
HDBR developing brain - 11 post …
T
32 Uhlen's Lab
T
19 NIH Epigenomics Roadmap
T
Hallstrom et al., 2014 - Organism part
T
GTEX - organism part
P
Proteomics
T
Transcriptomics
High
Medium
Low
Below cutoff
No data available

Filter your results

Kingdom
Species
Experiment type
Experimental variables
Regulation
-1
-1
1
2.2
Display log2-fold change
Download results
Log2-fold changeSpeciesGene nameComparisonExperimental variablesExperiment name
Adjusted p-valueLog2-fold change
9.6744 × 10-102.2
PRLH'blood alcohol content 0.04%declining' vs 'control' in 'time point 4'sampling time point, treatmentMicroarray characterization of gene expression changes in blood during acute ethanol exposure
Adjusted p-valueLog2-fold change
5.9751 × 10-91.8
PRLH'blood alcohol content 0.04%rising' vs 'control' in 'time point 2'sampling time point, treatmentMicroarray characterization of gene expression changes in blood during acute ethanol exposure
Adjusted p-valueLog2-fold change
1.2825 × 10-81.8
PRLH'blood alcohol content 0.02%declining' vs 'control' in 'time point 5'sampling time point, treatmentMicroarray characterization of gene expression changes in blood during acute ethanol exposure
Adjusted p-valueLog2-fold change
1.0266 × 10-81.7
PRLH'blood alcohol content 0%' vs 'control' in 'time point 1'sampling time point, treatmentMicroarray characterization of gene expression changes in blood during acute ethanol exposure
Adjusted p-valueLog2-fold change
3.0528 × 10-61.7
PRLH'1.25 micromolar dose of sapphyrin PCI-2050' vs '5 percent dose of mannitol'compoundTranscription profiling of human A549 lung cancer cells treated with actinomycin D and sapphyrin PCI-2050 a new class of tumor-selective inhibitors of gene expression.
Adjusted p-valueLog2-fold change
3.9365 × 10-81.6
PRLH'blood alcohol content 0.08%' vs 'control' in 'time point 3'sampling time point, treatmentMicroarray characterization of gene expression changes in blood during acute ethanol exposure
Adjusted p-valueLog2-fold change
9.5091 × 10-51.3
PRLH'Human betacoronavirus 2c EMC/2012' vs 'mock' at '24 hour'infect, timeTranscription profiling of human bronchial epithelial cell line Calu-3 2B4 infected with Human Coronavirus EMC 2012
Adjusted p-valueLog2-fold change
2.9932 × 10-51.2
PRLH'differentiated; hAKPC-P' vs 'undifferentiated; hIPod'cell type, phenotypeDifferentiation of human amniotic fluid kidney progenitor cells into podocytes and comparison with human conditionally immortalized podocytes
Adjusted p-valueLog2-fold change
2.9771 × 10-51.1
PRLH'differentiated; hAKPC-P' vs 're-differentiated; hIPod'cell type, phenotypeDifferentiation of human amniotic fluid kidney progenitor cells into podocytes and comparison with human conditionally immortalized podocytes
Adjusted p-valueLog2-fold change
1.3982 × 10-31.1
PRLH'2.25 micromolar dose of sapphyrin PCI-2050' vs '5 percent dose of mannitol'compoundTranscription profiling of human A549 lung cancer cells treated with actinomycin D and sapphyrin PCI-2050 a new class of tumor-selective inhibitors of gene expression.
Adjusted p-valueLog2-fold change
1.4468 × 10-41
PRLH'differentiated; hAKPC-P' vs 'undifferentiated; hAKPC-P'cell type, phenotypeDifferentiation of human amniotic fluid kidney progenitor cells into podocytes and comparison with human conditionally immortalized podocytes
Adjusted p-valueLog2-fold change
3.3722 × 10-4-1
PRLH'ovarian cancer' vs 'normal' in 'stromal cell'cell type, diseaseA cancer associated fibroblasts (CAFs) specific gene signature in high grade serous ovarian cancer
Adjusted p-valueLog2-fold change
7.8638 × 10-41
PRLH'cultured skin substitute; 28 day' vs 'skin; 0 day'organism part, timeTranscription profiling by array of human grafted engineered skin substitutes
Adjusted p-valueLog2-fold change
2.7834 × 10-2-1
PRLH'astrocytoma' vs 'normal'diseaseTranscription profiling of human grade II astrocytic tumor (astrocytomas) vs grade IV tumors (glioblastoma)